ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc (ADIL)

1.02
0.01
(0.99%)
終了 11月21日 6:00AM
1.02
0.00
( 0.00% )
プレマーケット: 7:26PM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
1.02
買値
1.01
売値
1.06
出来高
5,253
0.00 日の範囲 0.00
0.765 52 週間の範囲 4.12
時価総額
前日終値
1.02
始値
-
最終取引時間
19:26:27
財務取引量
-
VWAP
-
平均取引量 (3 か月)
143,290
発行済株式数
6,405,781
配当利回り
-
PER
-1.28
1 株当たり利益 (EPS)
-0.8
歳入
-
純利益
-5.12M

Adial Pharmaceuticals Inc について

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Adial Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ADIL. The last closing price for Adial Pharmaceuticals was US$1.02. Over the last year, Adial Pharmaceuticals shares have traded in a share price range of US$ 0.765 to US$ 4.12.

Adial Pharmaceuticals currently has 6,405,781 shares in issue. The market capitalisation of Adial Pharmaceuticals is US$6.53 million. Adial Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.28.

ADIL 最新ニュース

Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for...

Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

GLEN ALLEN, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

GLEN ALLEN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.09-8.108108108111.111.280.99245117031.10840902CS
4-0.08-7.272727272731.11.280.96961962231.0836954CS
120.055.154639175260.971.280.93551432901.06097355CS
26-0.46-31.08108108111.4830.914556811.28224587CS
52-1.1-51.88679245282.124.120.76523259311.96885023CS
156-73.98-98.647578.50.76511574426.24334639CS
260-38.98-97.45401270.765101082024.3864689CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WORXSCWorx Corporation
US$ 1.94
(97.96%)
11.68M
PETWag Group Company
US$ 0.338
(60.88%)
13.47M
VEEAVeea Inc
US$ 3.96
(40.43%)
2.71M
AKTSAkoustis Technologies Inc
US$ 0.1201
(37.89%)
23.29M
CCECCapital Clean Energy Carriers Corporation
US$ 24.99
(34.72%)
2
WSBFWaterstone Financial Inc
US$ 9.00
(-40.98%)
4
TRSTriMas Corporation
US$ 15.62
(-40.79%)
1
BCAXBicara Therapeutics Inc
US$ 11.00
(-40.15%)
104
XNCRXencor Inc
US$ 15.11
(-36.30%)
2
HSTMHealthStream Inc
US$ 20.00
(-36.10%)
102
AKTSAkoustis Technologies Inc
US$ 0.1201
(37.89%)
23.29M
PETWag Group Company
US$ 0.338
(60.88%)
13.47M
WORXSCWorx Corporation
US$ 1.94
(97.96%)
11.68M
XTKGX3 Holdings Company Ltd
US$ 0.0832
(-7.56%)
9.93M
ELABElevai Labs Inc
US$ 0.0207
(-3.27%)
2.92M

ADIL Discussion

投稿を表示